Down-regulation of Na/K + ATPase activity by human parvovirus B19 capsid protein VP1

Cellular Physiology and Biochemistry

Volumn 31, Issue 4-5, 2013, Pages 638-648

  Almilaji, Ahmad ^a,c   Szteyn, Kalina ^a,c   Fein, Evelyn ^b,c   Pakladok, Tatsiana ^a   Munoz, Carlos ^a   Elvira, Bernat ^a   Towhid, Syeda T ^a   Alesutan, Ioana ^a   Shumilina, Ekaterina ^a   Bock, C Thomas ^b   Kandolf, Reinhard ^b   Lang, Florian ^a,b  

^a Department of Physiology ^*  (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c KS   (Germany)

Author keywords

4 bromophenacylbromide; Lysophosphatidylcholine; Phospholipase A2; Viral myocarditis; VP1

Indexed keywords

4 BROMOPHENACYL BROMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); LYSOPHOSPHATIDYLCHOLINE; PROTEIN VP1; 4 BROMOPHENACYLBROMIDE; CYTIDINE PHOSPHATE; DACTINOMYCIN; OUABAIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; WATER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN PARVOVIRUS B19; NONHUMAN; OOCYTE; PRIORITY JOURNAL; VOLTAGE CLAMP; XENOPUS; ANIMAL EXPERIMENT; ANIMAL MODEL; CAPILLARY ENDOTHELIAL CELL; ELECTRIC POTENTIAL; ERYTHEMA INFECTIOSUM; FATALITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN ISOLATION; WHOLE CELL PATCH CLAMP;

MIRIDAE; PARVOVIRUS; STROPHANTHUS GRATUS;

EID: 84877848580     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000350083     Document Type: Article

References (82)

1. Heegaard ED, Brown KE: Human parvovirus B19. Clin Microbiol Rev 2002;15:485-505. (Pubitemid 34761354)
2. Brown KE, Young NS, Liu JM: Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994;16:1-31. (Pubitemid 24168469)
3. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, Cohen BJ, Mortimer PP, Pereira MS: Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983;1:1378. (Pubitemid 13100210)
4. Young NS, Brown KE: Parvovirus B19. N Engl J Med 2004;350:586-597.
5. Koch WC: Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001;14:343-356. (Pubitemid 32493548)
6. Lehmann HW, Knoll A, Kuster RM, Modrow S: Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 2003;48:1631-1638. (Pubitemid 36682371)
7. Pattison JR: Diseases caused by the human parvovirus B19. Arch Dis Child 1988;63:1426-1427. (Pubitemid 19011239)
8. Dingli D, Pfizenmaier DH, Arromdee E, Wennberg P, Spittell PC, Chang-Miller A, Clarke BL: Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 2000;356:312-314. (Pubitemid 30459595)
9. Trapani S, Ermini M, Falcini F: Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999;28:319-325. (Pubitemid 29211375)
10. Drago F, Semino M, Rampini P, Rebora A: Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 1999;141:160-161. (Pubitemid 29333716)
11. Hillingso JG, Jensen IP, Tom-Petersen L: Parvovirus B19 and acute hepatitis in adults. Lancet 1998;351:955-956. (Pubitemid 28138472)
12. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ: Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999;144:1713-1724. (Pubitemid 29490033)
13. Sokal EM, Melchior M, Cornu C, Vandenbroucke AT, Buts JP, Cohen BJ, Burtonboy G: Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 1998;352:1739-1741. (Pubitemid 28534956)
14. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S: Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996;347:868-869. (Pubitemid 26099540)
15. Corman LC, Dolson DJ: Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992;339:491.
16. Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR, et al.: Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994;343:1255-1258. (Pubitemid 24158047)
17. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR: Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001;358:729-730. (Pubitemid 32823406)
18. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192-1196. (Pubitemid 24121988)
19. Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R: Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003;34:92-95. (Pubitemid 36160027)
20. Kuhl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R: Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003;108:945-950. (Pubitemid 37048223)
21. Malm C, Fridell E, Jansson K: Heart failure after parvovirus B19 infection. Lancet 1993;341:1408-1409. (Pubitemid 23160007)
22. Murry CE, Jerome KR, Reichenbach DD: Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol 2001;32:342-345. (Pubitemid 32246811)
23. Nigro G, Bastianon V, Colloridi V, Ventriglia F, Gallo P, D'Amati G, Koch WC, Adler SP: Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 2000;31:65-69. (Pubitemid 32268940)
24. Orth T, Herr W, Spahn T, Voigtlander T, Michel D, Mertens T, Mayet WJ, Dippold W, Meyer zum Buschenfelde KH: Human parvovirus B19 infection associated with severe acute perimyocarditis in a 34-year-old man. Eur Heart J 1997;18:524-525. (Pubitemid 27110486)
25. Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, Rosenthal G, Kearney DL, Price JK, Rogers BB, Schauer GM, Chinnock RE, Towbin JA: Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997;96:3549-3554. (Pubitemid 27513432)
26. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R: Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 2004;193:101-107. (Pubitemid 38703777)
27. Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP: High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005;111:879-886. (Pubitemid 40279889)
28. Brown KE: What threat is human parvovirus B19 to the fetus? A review. Br J Obstet Gynaecol 1989;96:764-767. (Pubitemid 19186629)
29. Crane J: Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can 2002;24:727-743.
30. Katz VL, Chescheir NC, Bethea M: Hydrops fetalis from B19 parvovirus infection. J Perinatol 1990;10:366-368.
31. Oyer CE, Ongcapin EH, Ni J, Bowles NE, Towbin JA: Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction. Hum Pathol 2000;31:1433-1435.
32. Telerman A, Tuynder M, Dupressoir T, Robaye B, Sigaux F, Shaulian E, Oren M, Rommelaere J, Amson R: A model for tumor suppression using H-1 parvovirus. Proc Natl Acad Sci USA 1993;90:8702-8706. (Pubitemid 23277738)
33. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-117. (Pubitemid 23338882)
34. Weigel-Kelley KA, Yoder MC, Srivastava A: Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003;102:3927-3933. (Pubitemid 37486972)
35. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, Hirabayashi Y, Koyanagi Y, Sasaki T: Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005; 106:3449-3456. (Pubitemid 41609180)
36. Ellis PD, Metcalfe JC, Hyvonen M, Kemp PR: Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1. J Vasc Res 2003;40:234-243. (Pubitemid 36980725)
37. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P: Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 1986;60:548-557. (Pubitemid 17174893)
38. Doerig C, Beard P, Hirt B: A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 1987;157:539-542. (Pubitemid 17047710)
39. Mitchell LA: Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J Med Virol 2002;67:267-274. (Pubitemid 34493442)
40. Hsu TC, Wu WJ, Chen MC, Tsay GJ: Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand J Infect Dis 2004;36:570-577. (Pubitemid 39247978)
41. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K: Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998;72:3018-3028. (Pubitemid 28175541)
42. Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F: Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999;73:8762-8770. (Pubitemid 29441741)
43. Gigler A, Dorsch S, Hemauer A, Williams C, Kim S, Young NS, Zolla-Pazner S, Wolf H, Gorny MK, Modrow S: Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol 1999;73:1974-1979. (Pubitemid 29098099)
44. Canaan S, Zadori Z, Ghomashchi F, Bollinger J, Sadilek M, Moreau ME, Tijssen P, Gelb MH: Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 2004;279:14502-14508.
45. Li Y, Zadori Z, Bando H, Dubuc R, Fediere G, Szelei J, Tijssen P: Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid. J Gen Virol 2001;82:2821-2825. (Pubitemid 32998661)
46. Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P: A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 2001;1:291-302. (Pubitemid 33653063)
47. Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S: The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 2002;76:2014-2018. (Pubitemid 34094651)
48. Lupescu A, Bock CT, Lang PA, Aberle S, Kaiser H, Kandolf R, Lang F: Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1. J Virol 2006;80:11370-11380. (Pubitemid 44706577)
49. Rabini RA, Fumelli P, Zolese G, Amler E, Salvolini E, Staffolani R, Cester N, Mazzanti L: Modifications induced by plasma from insulin-dependent diabetic patients and by lysophosphatidylcholine on human Na+,K+-adenosine triphosphatase. J Clin Endocrinol Metab 1998;83:2405-2410. (Pubitemid 28503038)
50. Mohamed MR, Alesutan I, Foller M, Sopjani M, Bress A, Baur M, Salama RH, Bakr MS, Mohamed MA, Blin N, Lang F, Pfister M: Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss. Cell Physiol Biochem 2010;26:959-966.
51. Strutz-Seebohm N, Pusch M, Wolf S, Stoll R, Tapken D, Gerwert K, Attali B, Seebohm G: Structural basis of slow activation gating in the cardiac I Ks channel complex. Cell Physiol Biochem 2011;27:443-452.
52. Bohmer C, Sopjani M, Klaus F, Lindner R, Laufer J, Jeyaraj S, Lang F, Palmada M: The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell Physiol Biochem 2010;25:723-732.
53. Rexhepaj R, Dermaku-Sopjani M, Gehring EM, Sopjani M, Kempe DS, Foller M, Lang F: Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell Physiol Biochem 2010;26:641-646.
54. Alesutan IS, Ureche ON, Laufer J, Klaus F, Zurn A, Lindner R, Strutz-Seebohm N, Tavare JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F: Regulation of the glutamate transporter EAAT4 by PIKfyve. Cell Physiol Biochem 2010;25:187-194.
55. Hosseinzadeh Z, Bhavsar SK, Sopjani M, Alesutan I, Saxena A, Dermaku-Sopjani M, Lang F: Regulation of the glutamate transporters by JAK2. Cell Physiol Biochem 2011;28:693-702.
56. Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, Alesutan I, Eichenmuller M, Lang F: Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 2011;28:251-258.
57. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100. (Pubitemid 11012976)
58. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306. (Pubitemid 28070981)
59. Lang F: Mechanisms and significance of cell volume regulation. J Am Coll Nutr 2007;26:613S-623S. (Pubitemid 47512057)
60. Kaye DM, Kelly RA: Expression and regulation of the sodium-calcium exchanger in cardiac microvascular endothelial cells. Clin Exp Pharmacol Physiol 1999;26:651-655. (Pubitemid 29369927)
61. Pittner J, Rhinehart K, Pallone TL: Ouabain modulation of endothelial calcium signaling in descending vasa recta. Am J Physiol Renal Physiol 2006;291:F761-F769. (Pubitemid 44506972)
62. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000;1:11-21.
63. Fang KM, Chang WL, Wang SM, Su MJ, Wu ML: Arachidonic acid induces both Na+ and Ca2+ entry resulting in apoptosis. J Neurochem 2008;104:1177-1189.
64. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309-1312. (Pubitemid 28406816)
65. Orrenius S, Zhivotovsky B, Nicotera P: Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003;4:552-565. (Pubitemid 36773407)
66. Kerr PM, Tam R, Narang D, Potts K, McMillan D, McMillan K, Plane F: Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide. Can J Physiol Pharmacol 2012;90:739-752.
67. Bers DM, Despa S: Na/K-ATPase-an integral player in the adrenergic fight-or-flight response. Trends Cardiovasc Med 2009;19:111-118.
68. Lang F, Rehwald W: Potassium channels in renal epithelial transport regulation. Physiol Rev 1992;72:1-32.
69. Messner G, Wang W, Paulmichl M, Oberleithner H, Lang F: Ouabain decreases apparent potassium-conductance in proximal tubules of the amphibian kidney. Pflugers Arch 1985;404:131-137. (Pubitemid 15042658)
70. Volkl H, Geibel J, Greger R, Lang F: Effects of ouabain and temperature on cell membrane potentials in isolated perfused straight proximal tubules of the mouse kidney. Pflugers Arch 1986;407:252-257. (Pubitemid 16055736)
71. Rehwald W, Lang F: The effect of cyanide on apparent potassium conductance across the peritubular cell membrane of frog proximal tubules. Pflugers Arch 1986;407:607-610. (Pubitemid 17049017)
72. Koltsova SV, Trushina Y, Haloui M, Akimova OA, Tremblay J, Hamet P, Orlov SN: Ubiquitous [Na+]i/[K+] i-sensitive transcriptome in mammalian cells: evidence for Ca(2+)i-independent excitation-transcription coupling. PLoS One 2012;7:e38032.
73. Orlov SN, Hamet P: The death of cardiotonic steroid-treated cells: evidence of Na+i,K+i-independent H+i-sensitive signalling. Acta Physiol (Oxf) 2006;187:231-240.
74. Akimova OA, Lopina OD, Rubtsov AM, Gekle M, Tremblay J, Hamet P, Orlov SN: Death of ouabain-treated renal epithelial cells: evidence for p38 MAPK-mediated Na (i) (+)/K (i) (+)-independent signaling. Apoptosis 2009;14:1266-1273.
75. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D, Qadri SM, Lang F: p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-1286.
76. Shaik N, Lupescu A, Lang F: Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 2012;30:512-522.
77. Allan LA, Clarke PR: Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J 2009;276:6063-6073.
78. Hagemann C, Blank JL: The ups and downs of MEK kinase interactions. Cell Signal 2001;13:863-875. (Pubitemid 33139788)
79. Kostenko S, Dumitriu G, Laegreid KJ, Moens U: Physiological roles of mitogen-activated-protein-kinase-activated p38-regulated/activated protein kinase. World J Biol Chem 2011;2:73-89.
80. Myers CR, Myers JM, Kufahl TD, Forbes R, Szadkowski A: The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling. Mol Nutr Food Res 2011;55:1361-1374.
81. Sari FR, Widyantoro B, Thandavarayan RA, Harima M, Lakshmanan AP, Zhang S, Muslin AJ, Suzuki K, Kodama M, Watanabe K: Attenuation of CHOP-mediated myocardial apoptosis in pressure-overloaded dominant negative p38alpha mitogen-activated protein kinase mice. Cell Physiol Biochem 2011;27:487-496.
82. Shiryaev A, Moens U: Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: menage a trois or menage a quatre? Cell Signal 2010;22:1185-1192.